Taking nature's lead in the development of new and improved enzyme inhibitors

引领大自然开发新型和改良酶抑制剂

• 批准号: DP130101827
• 负责人: Prof Andrew Abell
• 金额: $ 27.72万
• 依托单位: The University of Adelaide
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-31 至 2016-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP130101827
• 关键词: Taking; nature; lead; development; new

This project will address some key fundamental issues associated with advancing a chemical entity from proof of principle through to a new pharmaceutical. The compounds in the study target cancer, cataract and other diseases that are confronting Australia's ageing population.

该项目将解决与推进化学实体从原理证明到新药物相关的一些关键基本问题。该研究中的化合物针对癌症，白内障和澳大利亚老龄化人口面临的其他疾病。